Clinical Trial Update: Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular Degeneration [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and pharmacodynamic study of emixustat in subjects with geographic atrophy associated with dry age-related macular degeneration has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• Emixustat (emixustat)

Snippet

Sponsor: Kubota Vision Inc. | Conditions: Geographic Atrophy, Age-Related Macular Degeneration | Phase 1 | Status: COMPLETED